A reliable model of intravenous MDMA self-administration in naive mice

被引:49
|
作者
Trigo, JM
Panayi, F
Soria, G
Maldonado, R
Robledo, P
机构
[1] Univ Pompeu Fabra, Barcelona 08003, Spain
[2] Inst Municipal Invest Med, E-08003 Barcelona, Spain
关键词
DAT; ecstasy; mazindol binding; operant responding; progressive ratio; reinforcement;
D O I
10.1007/s00213-005-0229-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: MDMA is one of the most widely consumed recreational drugs in Europe. However, the mechanisms involved in the reinforcing properties of MDMA are still unclear. In this sense, the establishment of a reliable model of MDMA self-administration in mice could represent an important approach to study the neuronal substrates associated with MDMA reward by using genetically modified mice. Objectives: To develop a reliable model of operant intravenous MDMA self-administration in drug-naive mice. Materials and methods: Mice were trained to acquire intravenous self-administration of MDMA at different doses (0, 0.06, 0.125, 0.25, 0.5 and 1.0 mg/kg/infusion) on a FR1 schedule of reinforcement for 15 consecutive days. The motivational value of different doses of MDMA (0.125, 0.25 and 0.5 mg/kg/infusion) was then tested using a progressive ratio paradigm. Finally, [H-3]-mazindol autoradiographic studies were carried out in order to quantitatively assess presynaptic dopamine transporter (DAT) binding sites in the striatum of mice trained to self-administer MDMA (0 and 1.0 mg/kg/infusion) during 15 days. Results: The latency for discrimination between the active and inactive holes, as well as the number of animals acquiring stability criteria, varied as a function of the dose of MDMA. The mice responding for intermediate doses (0.125, 0.25 and 0.5 mg/kg/infusion) discriminated earlier than those responding for low (0.06 mg/kg/infusion) or high (1.0 mg/kg/infusion) doses. The percentage of animals achieving stability criteria increased with days of testing and was inversely proportional to the dose of MDMA. The breaking points achieved for doses of 0.125 and 0.25 mg/kg/infusion were significantly higher than for a dose of 0.5 mg/kg/infusion. No significant DAT neurotoxicity was observed in the striatum of animals self-administering MDMA at a dose of 1 mg/kg/infusion. Conclusions: The present results show that MDMA can be reliably self-administered by drug-naive mice.
引用
收藏
页码:212 / 220
页数:9
相关论文
共 50 条
  • [41] INTRAVENOUS SELF-ADMINISTRATION OF DRUGS IN RATS
    VANREE, JM
    SLANGEN, JL
    WIED, DD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1978, 204 (03): : 547 - 557
  • [42] INTRAVENOUS COCAINE SELF-ADMINISTRATION IN RABBIT
    GROVE, RN
    VERREAULT, R
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1977, 1 (3-4): : 347 - 350
  • [43] INTRAVENOUS SELF-ADMINISTRATION OF NICOTINE IN THE BABOON
    ATOR, NA
    GRIFFITHS, RR
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 298 - 298
  • [44] INTRAVENOUS ALCOHOL SELF-ADMINISTRATION IN RAT
    SMITH, SG
    DAVIS, WM
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1974, 6 (04): : 397 - 402
  • [45] An operant social self-administration and choice model in mice
    Leslie A. Ramsey
    Fernanda M. Holloman
    Samantha S. Lee
    Marco Venniro
    Nature Protocols, 2023, 18 : 1669 - 1686
  • [46] Intravenous self-administration of cathinone by rats
    Gosnell, BA
    Yracheta, JM
    Bell, SM
    Lane, KE
    BEHAVIOURAL PHARMACOLOGY, 1996, 7 (06): : 526 - 531
  • [47] INTRAVENOUS SELF-ADMINISTRATION OF NOMIFENSINE IN THE RAT
    SPYRAKI, C
    FIBIGER, HC
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1981, 5 (03): : 313 - 314
  • [48] INTRAVENOUS SELF-ADMINISTRATION OF METALLIC MERCURY
    VAS, W
    TUTTLE, RJ
    ZYLAK, CJ
    RADIOLOGY, 1980, 137 (02) : 313 - 315
  • [49] An operant social self-administration and choice model in mice
    Ramsey, Leslie A. A.
    Holloman, Fernanda M. M.
    Lee, Samantha S. S.
    Venniro, Marco
    NATURE PROTOCOLS, 2023, 18 (06) : 1669 - 1686
  • [50] Prolonged self-administration of MDMA induces tolerance to its effects on the mesolimbic dopamine system in mice
    Orejarena, M. J.
    Maldonadon, R.
    Robledo, P.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S35 - S35